Biotech news
Americas
A collaboration between Bill Gates and Intellectual Ventures , in partnership with conglomerate GE, has signed a licensing deal with US diagnostics technology company Access Bio to make and sell tools for “rapidly” identifying asymptomatic malaria. 13 July 2017
Pharma
Precision medicine has come a long way since the completion of the Human Genome Project in 2003, but how have IP regimes developed in this area, asks Sheena Linehan of Potter Clarkson. 12 July 2017
Biotech
The European Patent Office has reopened cases in which the decision depends entirely on the patentability of plants or animals obtained by an essentially biological process. 11 July 2017
Biotech
More than 120 tons of counterfeit pesticides have been seized during an operation by Europol. 6 July 2017
Biotech
An advice system for labelling products in Mexico has been extended to food and non-alcoholic beverages. Daniel Sanchez and Victor Ramirez of Olivares report on how the regime works in practice. 30 June 2017
Biotech
The formal requirements for priority have become a hot topic at the European Patent Office, driven by their importance in high-profile oppositions to the Broad Institute’s CRISPR/Cas9 patents, as Catherine Coombes of HGF explains. 28 June 2017
Americas
The governor of Massachusetts has revealed a legislative proposal aimed at providing up to $500 million over the next five years in the life sciences sector. 26 June 2017
Americas
Earlier this month, the US Supreme Court handed down its decision in the biosimilars battle between Amgen and Sandoz, centring on the Biologics Price Competition and Innovation Act. 23 June 2017
Americas
“There’s one stick with this carrot—the whistleblower protection law,” explained Anne Elise Li, IP counsel at Crowell & Moring, in reference to the Defend Trade Secrets Act. 22 June 2017
Americas
The biotechnology industry is at a crossroads over 35 USC section 101, which covers patent sub-ject matter eligibility. 22 June 2017